Luly Jay R.
High convictionDirector, President and CEO · ENANTA PHARMACEUTICALS INC
Every open-market stock purchase Luly Jay R. has reported to the SEC on Form 4 that met our signal bar, parsed straight from the filings. Insiders sell for many reasons, but they buy with their own money for one — this page tracks where how the prices paid compare to where the stock trades now.
Where the buys stand today
- ENTAENANTA PHARMACEUTICALS INC
One purchase totalling $256.1K at an average of $5.69 per share. See all insider buying in ENTA →
Avg price paid$5.69Latest price—Market capUnknown
All reported buys
Get alerted the next time Luly Jay R. — or any insider — buys
We watch every Form 4 as it hits SEC EDGAR and alert you when insiders cluster into the same stock.
About this data
Figures are parsed from Luly Jay R.'s Form 4 filings on SEC EDGAR (CIK 1571211) and cover open-market purchases (transaction code P) — grants, option exercises, and sales are excluded, which is why totals here can differ from raw filing counts. Every row links to its source document.
This page is informational and reflects public filing data. It is not investment advice.